| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |